Screening for Osteoporosis in Men Over Fifty With No Fracture History

Osteoporosis is a major public health concern that affects both men and women, yet it remains significantly underdiagnosed in men over fifty, particularly those without a prior history of fractures. While the risk of osteoporotic fractures increases with age, screening guidelines have primarily targeted postmenopausal women, leaving a gap in early detection and preventive care for older men. Despite evidence indicating high morbidity and mortality associated with fractures in men, routine screening is not consistently recommended or implemented in this demographic. Risk assessment tools such as FRAX are commonly used to estimate fracture probability, but their performance in asymptomatic men without fracture history has shown limitations. These models often rely on data derived from predominantly female populations and may not account for male-specific risk factors like testosterone deficiency, comorbidities, or subtle declines in bone quality. Furthermore, inconsistencies in guideline recommendations across organizations contribute to clinical uncertainty and variation in practice. Some advocate for screening men over seventy, while others suggest screening only in the presence of identifiable risk factors, leaving many men untested despite being at elevated risk. Early detection strategies, including the integration of clinical risk profiling into routine care and opportunistic screening during chronic disease management, offer a pathway to improved outcomes. Community outreach programs and technological advances in imaging and biomarker analysis may also support broader identification of at-risk individuals. A more unified and evidence-based approach to screening men over fifty, regardless of fracture history, may improve diagnosis rates and reduce long-term complications. Addressing current limitations in screening protocols and enhancing risk assessment accuracy are key steps toward closing the gap in osteoporosis care for older men.